The ongoing and future clinical trials in T1D patients will be crucial for determining where CT-868 stands in comparison to existing treatments, both in terms of minimizing the risk of complications associated with T1D and addressing the specific needs of the overweight or obese T1D population
But weight loss injections like Mounjaro and Wegovy keep the levels of this hormone higher for longer
That began to change about 20 years ago
While individuals appear able to tolerate small increases in exercise relative to their normal routine, larger increases in training load are associated with higher heart rate and persistently lower HRV during GLP treatment[5]
Zheng H, Li YF, Zucker IH, Patel KP
Failure to meet these thresholds typically results in treatment discontinuation, as cost-effectiveness is not demonstrated with lesser responses